Peptide for skin regeneration or wound treatment and use thereof
Provided is a novel peptide for skin regeneration or wound healing and a use thereof. The novel peptide not only promotes the wound healing by increasing the production amount of collagen in dermal fibroblasts but also has an excellent whitening effect by inhibiting the production amount of melanin and tyrosinase activity of melanoma cells, and consists of peptides having a very small size to minimize side effects according to administration of external substances of very small peptides. As a result, it is expected that the novel peptide can be used as an active substance that can replace existing skin regeneration or would therapeutic agents.
1. A synthetic peptide selected from the amino acid sequence consisting of SEQ ID NO: 1 or the amino acid sequence consisting of SEQ ID NO: 2, wherein the N- or C-terminal of the synthetic peptide is attached to a protective group selected from the group consisting of an acetyl group, a fluorenylmethoxy carbonyl group, a formyl group, a palmitoyl group, a myristyl group, a stearyl group, a polyethylene glycol (PEG) group, a methyl group, an amide group, an albumin group, a polysialic acid (PSA) group, a hydroxyethyl starch (HES) group, and a C12-C18 fatty acid group.
2. A method for skin regeneration or wound healing, comprising the step of administering a composition comprising a pharmaceutically effective amount of a synthetic peptide or a polynucleotide encoding the peptide as an active ingredient to a subject or subject having a wound, wherein the synthetic peptide is selected from the amino acid sequence consisting of SEQ ID NO: 1 or SEQ ID NO: 2.
3. The method of claim 2 , wherein the N- or C-terminal of the synthetic peptide is attached to a protective group selected from the group consisting of an acetyl group, a fluorenylmethoxy carbonyl group, a formyl group, a palmitoyl group, a myristyl group, a stearyl group, or a polyethylene glycol (PEG) group, a methyl group, an amide group, an albumin group, a polysialic acid (PSA) group, a hydroxyethyl starch (HES) group, and a C12-C18 fatty acid group.
4. The method of claim 2 , wherein the peptide is contained at a concentration of 1 to 500 ng/ml.
5. The method of claim 2 , wherein the wound is a gash.
6. The method of claim 2 , wherein the composition further comprises a pharmaceutically acceptable carrier.
7. A method for improving skin aging or wound healing, comprising the step of administering a composition comprising a cosmetically effective amount of a synthetic peptide or a polynucleotide encoding the peptide as an active ingredient to a subject or subject having a wound, wherein the synthetic peptide is selected from the amino acid sequence consisting of SEQ ID NO: 1 or SEQ ID NO: 2.
8. The method of claim 7 , wherein the N- or C-terminal of the synthetic peptide is attached to a protective group selected from the group consisting of an acetyl group, a fluorenylmethoxy carbonyl group, a formyl group, a palmitoyl group, a myristyl group, a stearyl group, or a polyethylene glycol (PEG) group, a methyl group, an amide group, an albumin group, a polysialic acid (PSA) group, a hydroxyethyl starch (HES) group, and a C12-C18 fatty acid group.
9. The method of claim 7 , wherein the composition is in the form of suspension, emulsion, paste, gel, cream, lotion, powder, wax or spray.
10. The method of claim 7 , wherein the composition has a skin whitening activity.
11. The synthetic peptide of claim 1 , wherein the amino acid sequence consists of SEQ ID NO: 1.
12. A synthetic peptide with an amino acid sequence consisting of SEQ ID NO: 2.
13. A pharmaceutical composition comprising a synthetic peptide with an amino acid sequence consisting of SEQ ID NO: 2 and a pharmaceutically acceptable carrier.